Search for: "In re: Blood Reagents Antitrust Litig." Results 1 - 8 of 8
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Sep 2009, 9:13 pm
§ 1407, Unopposed by Class Action Plaintiffs or Common Defendants, and Transfers Actions to Eastern District of Pennsylvania Ten (10) class actions – eight in New Jersey, one in New York and one in Pennsylvania – were filed against various defendants alleging antitrust violations; specifically, the class action complaints allege “price fixing in a claimed nationwide market for blood reagent products and seek recovery under federal antitrust… [read post]
29 Jul 2009, 6:42 am
Marketing and Sales Practices Litig., MDL No. 2078; and In re Blood Reagents Antitrust Litig., MDL No. 2081. [read post]
16 Apr 2015, 5:26 am
  The latest win is in In re Actiq Sales & Marketing Practices Litigation, ___ F.R.D. ___, 2015 WL 1312015 (E.D. [read post]
14 May 2018, 7:17 am by Seyfarth Shaw LLP
Health Sys., 669 F.3d 802, 812 (7th Cir. 2012), and of the Third Circuit’s ruling of In Re Blood Reagents Antitrust Litig., 783 F.3d 183, 187 (3d Cir. 2015), both of which suggest that class certification evidence must be admissible. [read post]